Skip to Content
Merck
  • SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Nature cell biology (1999-11-13)
A C Carrano, E Eytan, A Hershko, M Pagano
ABSTRACT

Degradation of the mammalian cyclin-dependent kinase (CDK) inhibitor p27 is required for the cellular transition from quiescence to the proliferative state. The ubiquitination and subsequent degradation of p27 depend on its phosphorylation by cyclin-CDK complexes. However, the ubiquitin-protein ligase necessary for p27 ubiquitination has not been identified. Here we show that the F-box protein SKP2 specifically recognizes p27 in a phosphorylation-dependent manner that is characteristic of an F-box-protein-substrate interaction. Furthermore, both in vivo and in vitro, SKP2 is a rate-limiting component of the machinery that ubiquitinates and degrades phosphorylated p27. Thus, p27 degradation is subject to dual control by the accumulation of both SKP2 and cyclins following mitogenic stimulation.